Autosomal dominant Charcot-Marie-Tooth neuropathy and deafness is a rare inherited nerve disease. In this condition, the long nerves to the feet and hands become damaged, and the hearing nerve or inner ear is also affected. This causes weakness and wasting of muscles in the legs and hands, numbness or tingling, and slowly worsening hearing loss (usually sensorineural deafness).NCBI+1
Autosomal dominant Charcot-Marie-Tooth neuropathy and deafness is a rare inherited nerve disease in which a single changed gene from one parent is enough to cause illness. In this condition, the myelin or axons of peripheral nerves are damaged, so signals between the brain, limbs, and inner ear travel slowly or are partly lost. People usually develop weakness and wasting of muscles in the feet and hands, loss of feeling, balance problems, foot deformities, and sensorineural hearing loss that can progress to deafness. Because the problem is genetic, it is long-lasting, but good care can support walking, hand use, communication, and overall quality of life.MedlinePlus+3NCBI+3MalaCards+3
“Autosomal dominant” means a person needs only one changed (mutated) copy of the gene to have the disease. If a parent has this condition, each child has a 50% chance of inheriting the faulty gene. Men and women are usually affected in a similar way, and symptoms often start in childhood or teenage years, but sometimes later in adult life.NCBI+1
This disease belongs to the Charcot-Marie-Tooth (CMT) group of hereditary motor and sensory neuropathies. In the “neuropathy and deafness” form, the nerves that control movement and feeling in the limbs are damaged, and the parts of the hearing system that depend on healthy nerves also stop working properly. Hearing loss is usually in both ears and often affects higher-pitched sounds and speech understanding in noise.Charcot-Marie-Tooth Association+2MedlinePlus+2
In many families, this specific form is called CMT type 1E, which is a demyelinating neuropathy, meaning the myelin coating of the nerves is damaged. The same clinical picture can also appear in some axonal CMT forms such as CMT2C or CMT2J, where the main problem is damage to the nerve fiber (axon) itself, but the end result is still weakness, sensory loss, and hearing difficulty.UniProt+2Global Genes+2
Other names and types
This condition can be described with several names in the medical literature. These include:
Charcot-Marie-Tooth disease and deafness (CMT1E) – a well-known autosomal dominant form with demyelinating neuropathy and sensorineural hearing loss.MalaCards+1
Charcot-Marie-Tooth disease, demyelinating, type 1E – focuses on damage to the myelin sheath of peripheral nerves.UniProt+1
Hereditary motor and sensory neuropathy with deafness – an older term that describes neuropathy and sensorineural deafness in the same family.Journal of Pediatrics+1
Autosomal dominant Charcot-Marie-Tooth disease type 2C (CMT2C) – an axonal form that can include weakness, vocal cord problems, breathing muscle weakness, and hearing loss.Global Genes+1
Autosomal dominant Charcot-Marie-Tooth disease type 2J (CMT2J) – an axonal CMT with distal weakness and sometimes deafness in many patients.Orpha+1
Hereditary motor and sensory neuropathy type IIC (HMSN IIC) – another name for CMT2C, stressing both motor and sensory nerve involvement.MalaCards+1
Hereditary sensory neuropathy with hearing loss – emphasises the sensory nerve and hearing parts of the syndrome.NCBI+1
Hereditary neuropathy with sensorineural hearing loss – a general term when the exact CMT subtype is not known but both neuropathy and deafness are present.PM&R KnowledgeNow+1
These different labels reflect that more than one gene and more than one CMT subtype can give a similar picture of nerve damage in the limbs together with progressive hearing loss.NCBI+1
Causes
1. Mutations in myelin protein zero (MPZ) gene
Changes in the MPZ gene, which codes for a key myelin protein in peripheral nerves, are a well-known cause of autosomal dominant CMT with demyelination. Some MPZ mutations are linked to forms that also include hearing loss, because the same or related proteins are needed for normal function of auditory pathways.NCBI+1
2. Mutations in peripheral myelin protein 22 (PMP22) gene
Abnormal PMP22 gene changes, including point mutations and special deletions, can produce a variant where CMT neuropathy and deafness occur together. A unique PMP22 mutation has been described in families with both neuropathy and sensorineural hearing loss, showing how a single gene error can affect both limb nerves and hearing nerves.BJORL+1
3. PMP22 duplication or deletion with atypical features
The common PMP22 duplication that causes CMT1A and the deletion that causes hereditary neuropathy with liability to pressure palsies (HNPP) usually do not cause deafness, but in some families extra neurological signs like hearing problems, pyramidal signs, or other features have been reported. This shows that the same basic gene change can sometimes lead to broader symptoms.NCBI+1
4. TRPV4 gene mutations (CMT2C)
Mutations in the TRPV4 gene can cause autosomal dominant CMT2C, a peripheral axonal neuropathy that often includes sensorineural hearing loss and vocal cord weakness. In this form, the damaged ion channel protein affects many motor and sensory neurons, including those involved in breathing and hearing.Global Genes+1
5. Other autosomal dominant CMT genes with hearing involvement
Many other genes can cause autosomal dominant CMT, such as GJB1, MFN2, and others. In some families, specific mutations in these genes are associated with hearing loss, probably because the same proteins are expressed in both peripheral nerves and parts of the auditory pathway.NCBI+1
6. Abnormal myelin structure in auditory pathways
Demyelination in CMT affects not only the long nerves in the arms and legs but can also affect parts of the auditory nerve and brainstem pathways. Abnormal myelin leads to slower electrical conduction and timing problems in sound signals, which can appear as delayed brainstem auditory responses and hearing loss.PMC+1
7. Axonal degeneration in auditory nerve fibers
In axonal forms like CMT2J or CMT2C, the nerve fiber itself gradually dies back. When this process involves auditory nerve fibers, the person may experience “hidden” hearing loss, with normal standard hearing tests but poor hearing in noise, and later more obvious deafness.Global Genes+1
8. Dominant negative effect of mutant proteins
Some mutant proteins in autosomal dominant CMT act in a “dominant negative” way. This means the faulty protein interferes with the normal protein from the healthy gene copy. This can disrupt myelin or axonal structure in multiple nerve systems at once, including those used for hearing.JAMA Network+1
9. Endoplasmic reticulum stress and cell toxicity
Certain CMT-related mutations cause proteins to misfold and build up inside nerve cells, leading to stress and toxic signals inside the cell. Chronic stress in this system can trigger cell damage or death in both long peripheral nerves and auditory neurons, contributing to neuropathy and deafness together.PMC+1
10. Mitochondrial dysfunction in nerves
Some CMT forms involve secondary mitochondrial problems in peripheral nerve cells. Damaged mitochondria cannot provide enough energy for long nerves, including those in the auditory pathway, which may promote gradual loss of both limb nerve function and hearing ability.NCBI+1
11. Genetic heterogeneity within demyelinating CMT
Within autosomal dominant demyelinating CMT, there is large genetic and clinical variety. Some of these variants include deafness as an extra feature, reflecting that different mutations within the same or related genes can affect the nervous system in slightly different ways, including hearing.SciELO Costa Rica+1
12. De novo (new) mutations
Not all patients have a clear family history. Some have a new mutation that appears for the first time in them. These de novo mutations can affect CMT genes such as PMP22 or MPZ and cause neuropathy and deafness even when parents are healthy, but the mutation can then be passed on in an autosomal dominant way to their children.NCBI+1
13. Incomplete penetrance and variable expression
In some families, not every person who inherits the mutation shows the same level of symptoms. Some may have clear neuropathy and deafness, while others have only mild neuropathy or almost no hearing problems. This incomplete penetrance and variable expression are common features of autosomal dominant CMT genes.MalaCards+1
14. Age-related nerve damage on top of genetic weakness
As people age, nerves naturally lose some function. When someone already has a CMT mutation, this normal age-related decline may push nerve function below the level needed for normal movement and hearing, making weakness and hearing loss show up or worsen later in life.NCBI+1
15. Repeated mechanical stress on already fragile nerves
Long nerves with CMT are more vulnerable to mechanical stress such as compression or stretching. Repeated minor injuries to peripheral or auditory nerves may speed up nerve damage and contribute to earlier or more severe symptoms, including hearing loss in some people.PM&R KnowledgeNow+1
16. Coexisting middle ear or inner ear disease
Some patients with CMT may also develop unrelated ear problems, such as chronic otitis media or age-related inner ear damage. When combined with nerve-related hearing loss from CMT, this can make deafness more severe, although these ear diseases are not the primary cause of CMT.MedlinePlus+1
17. Exposure to ototoxic drugs in someone with CMT
Drugs that damage hearing, such as some aminoglycoside antibiotics or platinum chemotherapy, can cause additional hearing loss in people who already have a vulnerable auditory system because of CMT. In such cases, the genetic neuropathy and the drug effect act together to worsen deafness.Lippincott Journals+1
18. Coexisting metabolic neuropathies (for example, diabetes)
If a person with autosomal dominant CMT also develops diabetes or another metabolic neuropathy, the combined effect can make peripheral nerve damage worse. Although diabetes does not cause CMT, it can add extra nerve damage and may worsen balance and sensory problems, which may indirectly affect hearing rehabilitation and stability.PM&R KnowledgeNow+1
19. Inflammatory or immune factors on top of CMT
Some patients with a CMT mutation may also develop an acquired inflammatory neuropathy. In these rare “double hit” cases, the inherited neuropathy and the immune attack together lead to more severe nerve damage, which may affect many nerve functions including hearing.NCBI+1
20. Environmental noise exposure in a vulnerable auditory system
Long-term loud noise exposure can cause hearing loss in any person. In someone whose auditory nerve is already affected by a CMT gene mutation, this noise damage may lead to earlier or more severe deafness than in the general population, even though noise exposure by itself does not cause the genetic disease.Charcot-Marie-Tooth Association+1
Symptoms
1. Progressive weakness in feet and lower legs
One of the first signs is often weakness in the muscles that lift the foot and move the ankle. People may notice difficulty running, climbing stairs, or walking on uneven ground as the nerve supply to these muscles becomes weaker over time.NCBI+1
2. Foot deformities such as high arches and hammer toes
Because some muscles are weaker than others, the shape of the foot slowly changes. Many people develop high arched feet (pes cavus), clawed or hammer toes, or a very narrow foot, which can make shoe fitting and walking more difficult over years.NCBI+1
3. Sensory loss in feet and legs
People commonly describe numbness, reduced feeling, or “cotton” sensations in the feet and lower legs. They may not feel light touch, pain, temperature, or vibration as well as before, which increases the risk of unnoticed injuries.NCBI+1
4. Balance problems and frequent tripping
Weakness in the ankle muscles and loss of position sense from the feet make it harder for the brain to control balance. This leads to frequent tripping, ankle twisting, and difficulty walking in the dark or on rough surfaces.NCBI+1
5. Foot drop and steppage gait
Because the front-of-shin muscles that lift the foot are weak, the toes may drag on the ground. To avoid falling, people often lift their knees higher when they walk, creating a characteristic “steppage” gait that doctors recognise in CMT.NCBI+1
6. Weakness and wasting in hands and forearms
With time, the neuropathy may move upwards and affect the hands. People may find it harder to do fine tasks such as buttoning clothes, writing, using keys, or handling small objects, and the small hand muscles may look thinner.NCBI+1
7. Reduced or absent tendon reflexes
Doctors often find that ankle reflexes are reduced or absent, and later knee or upper limb reflexes can also weaken. This happens because the reflex loop depends on healthy sensory and motor nerves, which are damaged in CMT.NCBI+1
8. Neuropathic pain or uncomfortable sensations
Some people feel burning, tingling, electric shocks, or deep aching pains in their feet and legs. These abnormal sensations come from damaged nerves firing in an irregular way, and can interfere with sleep and daily comfort.NCBI+1
9. Progressive sensorineural hearing loss
In this specific form, the hearing loss is usually sensorineural, meaning it comes from damage to the inner ear or auditory nerve rather than the outer or middle ear. Hearing loss often affects both ears, starts in higher frequencies, and may slowly get worse over years.MalaCards+1
10. Difficulty understanding speech, especially in noise
Many people complain that they “hear but do not understand,” especially in noisy rooms, group conversations, or when several people talk at once. This difficulty reflects both hearing loss at certain pitches and problems with timing and processing of sound in the auditory nerve and brainstem.Charcot-Marie-Tooth Association+1
11. Tinnitus (ringing or buzzing in the ears)
Some patients experience ringing, buzzing, or hissing sounds in their ears, called tinnitus. This can be mild or very disturbing, and it arises when damaged hearing pathways send abnormal signals even when no outside sound is present.Lippincott Journals+1
12. Delayed or abnormal brainstem auditory responses
Although patients do not feel this directly, tests often show delayed brainstem auditory evoked responses. This delay reflects slower conduction of sound signals in the demyelinated auditory pathways and is part of the objective evidence of hearing nerve involvement.Lippincott Journals+1
13. Fatigue and reduced stamina
Walking with weak muscles and poor balance takes more effort. People with autosomal dominant CMT and deafness often feel tired more easily, need to rest after physical activity, and may reduce their participation in sports or long walks.PM&R KnowledgeNow+1
14. Emotional and social impact
Hearing loss and visible walking problems can affect self-confidence, work, and social life. People may avoid groups because of communication problems, or feel anxious about falling, which can lead to isolation or low mood if support is not provided.Charcot-Marie-Tooth Association+1
15. Possible breathing or voice problems in some subtypes
In subtypes such as CMT2C, respiratory muscles and vocal cords can be involved. Some patients may notice shortness of breath, especially when lying down, or a weak or hoarse voice due to vocal cord paresis, along with neuropathy and hearing loss.Global Genes+1
Diagnostic tests
1. Detailed neurological history and family pedigree
The doctor starts by asking about when symptoms began, how they have changed over time, and whether other family members have similar problems. Drawing a family tree helps to see the autosomal dominant pattern, with affected people in many generations, which strongly suggests a hereditary neuropathy.NCBI+1
2. General neurological examination
A full exam looks at muscle strength, muscle bulk, tone, reflexes, and sensation. Typical findings include distal weakness, muscle wasting in feet and hands, reduced vibration and pinprick sensation, and reduced tendon reflexes, all pointing to a length-dependent peripheral neuropathy like CMT.NCBI+1
3. Musculoskeletal examination of feet and hands
The doctor checks for high arches, hammer toes, clawing, ankle instability, and hand muscle wasting. These structural changes support a long-standing neuropathy and help distinguish inherited neuropathy from short-term acquired nerve problems.NCBI+1
4. Gait and posture observation
Watching the way a person walks can reveal foot drop, steppage gait, poor heel strike, or difficulty with tandem walking (heel-to-toe). These visible signs give simple but strong evidence that the motor nerves to the legs are not working properly.PM&R KnowledgeNow+1
5. Romberg balance test
In the Romberg test, the person stands with feet together, first with eyes open and then with eyes closed. Increased swaying or loss of balance when the eyes are closed suggests impaired position sense from the feet, which is common in sensory neuropathy.PM&R KnowledgeNow+1
6. Manual muscle testing (MRC grading)
The doctor uses hands to test each muscle group and grades strength on a standard scale (Medical Research Council scale) from 0 to 5. Distal muscles, especially ankle dorsiflexors and intrinsic hand muscles, are usually weaker than proximal muscles, which fits with CMT.PM&R KnowledgeNow+1
7. Bedside sensory testing
Simple tools like cotton, pin, tuning fork, and warm or cold objects are used to test touch, pain, vibration, and temperature. In autosomal dominant CMT, vibration and position sense in the feet are often particularly reduced, supporting the diagnosis of length-dependent sensory neuropathy.NCBI+1
8. Tuning fork tests (Rinne and Weber)
For hearing, the doctor places a vibrating tuning fork on the mastoid bone and near the ear canal to compare bone and air conduction (Rinne test), and on the forehead to see which ear hears best (Weber test. In sensorineural hearing loss, air conduction is better than bone, but sound is reduced in the affected ear, helping to distinguish nerve deafness from middle ear problems.Lippincott Journals+1
9. Whispered voice and speech discrimination tests
The clinician may whisper words or numbers from behind the patient or use simple word lists in a quiet and in a noisy room. Poor performance, especially for high-pitched sounds or in noise, suggests sensorineural hearing loss that fits the CMT-related deafness picture.Charcot-Marie-Tooth Association+1
10. Functional walking tests (heel, toe, and tandem walking)
Asking the person to walk on heels, on toes, and in a straight line heel-to-toe helps measure functional impact of weakness and balance problems. Difficulty with heel walking is common in foot drop, and problems with tandem walking show impaired balance from sensory loss.PM&R KnowledgeNow+1
11. Genetic panel testing for CMT genes
A blood sample is taken and sent for a CMT gene panel, which tests many known genes at once, including PMP22, MPZ, TRPV4, GJB1, and others. Identifying a pathogenic variant confirms the hereditary nature of the neuropathy and can also explain the association with deafness when the gene is known to affect auditory pathways.NCBI+1
12. Targeted testing for PMP22, MPZ, or TRPV4 variants
If the clinical picture and family history point strongly to specific subtypes like CMT1E or CMT2C, more focused testing can be done. Detecting a known PMP22, MPZ, or TRPV4 mutation in an affected person and other family members provides very strong evidence of autosomal dominant CMT with deafness.BJORL+2UniProt+2
13. Blood tests to rule out acquired neuropathies
Tests such as fasting glucose, HbA1c, vitamin B12, thyroid function, kidney and liver tests, and some immune markers are used to exclude common acquired causes of neuropathy. Normal results, together with a family history, support the diagnosis of hereditary neuropathy rather than a secondary cause.PM&R KnowledgeNow+1
14. Nerve conduction studies (NCS)
Electrodes are placed on the skin over nerves and muscles to measure how fast and how strongly nerves conduct electrical signals. In demyelinating forms like CMT1E, conduction velocities are markedly slowed, while in axonal forms like CMT2C they are relatively preserved but amplitudes are reduced.NCBI+1
15. Electromyography (EMG)
A fine needle electrode is inserted into muscles to record electrical activity at rest and during contraction. EMG helps confirm chronic denervation and re-innervation patterns typical of a long-standing neuropathy, and it helps rule out primary muscle disease.NCBI+1
16. Pure-tone audiometry (PTA)
During PTA, the patient wears headphones and indicates when they hear tones at different frequencies and loudness levels. Results show the degree and pattern of hearing loss, which in CMT-related deafness is usually bilateral sensorineural and often worse at higher frequencies.Lippincott Journals+1
17. Speech audiometry and speech-in-noise testing
These tests measure how well a person can understand spoken words at different loudness levels and in background noise. People with CMT-related hearing loss may have poor speech understanding in noise, even when tones are still heard, reflecting nerve timing and processing problems.Charcot-Marie-Tooth Association+1
18. Brainstem auditory evoked responses (ABR/BAEP)
Small electrodes on the scalp measure electrical responses from the brainstem after sound clicks. In demyelinating CMT forms, inter-peak latencies are often prolonged, meaning sound signals travel more slowly through the auditory brainstem pathways, giving objective proof of nerve involvement.Lippincott Journals+1
19. Otoacoustic emissions (OAE) testing
A tiny probe is placed in the ear canal to measure sounds produced by the outer hair cells of the cochlea in response to clicks. OAEs can help distinguish cochlear from retrocochlear (nerve) problems; in some CMT patients, OAEs may be relatively preserved while ABR is abnormal, supporting the idea of auditory neuropathy.Nature+1
20. MRI of brain and internal auditory canals
Magnetic resonance imaging can be used to rule out other structural causes of hearing loss, such as tumors on the hearing nerve or brainstem lesions. A normal MRI, together with evidence of peripheral neuropathy and abnormal auditory nerve conduction, supports the diagnosis of hereditary CMT-related neuropathy and deafness rather than another central problem.Lippincott Journals+1
Non-Pharmacological Treatments (Therapies and Others Items)
Below are key non-drug therapies. In real life, a multidisciplinary team (neurologist, audiologist, physiotherapist, orthopedist, genetic counselor, psychologist) chooses and combines them for each patient based on age, gene type, severity, and daily needs.NCBI+2Charcot-Marie-Tooth Association+2
Individualized Physical Therapy
Physical therapy uses stretching, strengthening, balance training, and gait exercises to keep muscles working for as long as possible. The purpose is to slow contractures, improve walking safety, and maintain independence. The main mechanism is repeated, targeted movement that keeps joints loose, activates remaining motor units, and builds compensating muscle groups to support weak ankles, knees, and hips.Occupational Therapy and Hand Training
Occupational therapists teach joint-protection techniques and provide exercises for fine motor skills such as buttoning, writing, and keyboard use. The purpose is to let people continue school, work, and self-care tasks. The mechanism is guided practice using adaptive grips, splints, and task-specific training that helps the brain and hands find easier movement patterns despite neuropathy.Ankle-Foot Orthoses (AFOs)
AFOs are custom braces worn inside or around shoes to hold the ankle at the right angle, reduce foot drop, and prevent tripping. The purpose is safer walking and less fatigue. Mechanistically, they provide external support and alignment, making up for weak dorsiflexor muscles and stabilizing the ankle during the stance and swing phases of gait.NCBICustom Footwear and Orthotic Insoles
Special shoes and insoles redistribute pressure, correct mild deformities, and improve balance. Their purpose is to reduce calluses, ulcers, and pain and to make walking smoother. The mechanism is mechanical: extra depth, arch support, and lateral support hold the foot in a more neutral position and reduce strain on ligaments and small muscles.Gait and Balance Training Programs
These programs use parallel bars, balance boards, treadmill practice, and obstacle courses. The purpose is to lower fall risk and build confidence. The mechanism is neuroplastic: repeated training encourages the central nervous system to use vision, inner-ear balance, and remaining sensory input more efficiently when peripheral nerves are weak or numb.Hearing Aids
Digital hearing aids amplify sound and adjust frequency ranges to match the person’s hearing loss pattern. The purpose is clearer speech perception and easier communication in daily life. The mechanism is acoustic amplification with digital filtering that boosts speech frequencies, reduces background noise, and partly compensates for damaged cochlear or auditory nerve pathways.Charcot-Marie-Tooth Association+1Cochlear Implants
Cochlear implants are electronic devices surgically placed in the inner ear to convert sound into electrical signals sent directly to the auditory nerve. They are considered when hearing aids no longer help. The mechanism is electrical stimulation of surviving auditory nerve fibers to restore more synchronous firing and improve speech understanding even in people with CMT-related auditory neuropathy.PMC+2Charcot-Marie-Tooth News+2Assistive Listening Devices (ALDs)
FM systems, Bluetooth microphones, and loop systems send a speaker’s voice directly to a receiver or hearing aid. The purpose is better hearing in noisy classrooms, meetings, and public places. The mechanism is improving the signal-to-noise ratio by bringing the speech signal closer to the ear and bypassing part of the acoustic environment.Speech and Communication Therapy
Speech therapists help with speech clarity, lip-reading skills, and sometimes sign-supported communication. The purpose is to keep communication effective even as hearing and articulation change. The mechanism is structured practice with feedback that trains both the speaker and the listener to use visual cues, slower speech, and clearer articulation patterns.Sign Language and Visual Communication Training
Learning sign language and visual cues gives an alternative channel when hearing is very poor. The purpose is to prevent social isolation and allow rich communication without sound. The mechanism is using visual-manual symbols processed by visual brain areas, completely bypassing the damaged cochlear pathway.Pain Coping Skills and Cognitive-Behavioral Therapy (CBT)
Chronic neuropathic pain can worsen disability and mood. CBT teaches pacing, relaxation, and coping strategies. The purpose is to reduce the impact of pain on life quality. The mechanism is psychological: changing pain-related thoughts and behaviours can reduce perceived pain intensity and improve sleep and mood, even if the nerves remain damaged.Psychological Counseling and Peer Support
Depression and anxiety are common in long-term neurological disease. Counseling and patient groups give emotional support, education, and problem-solving tools. The mechanism is social and psychological: feeling understood, sharing experiences, and learning coping strategies can reduce distress and improve adherence to therapies.U.S. Food and Drug AdministrationGenetic Counseling for Patients and Families
Genetic counselors explain inheritance patterns, recurrence risks, and testing options. The purpose is informed family planning and early diagnosis in relatives. The mechanism is education and decision support, helping families understand autosomal dominant transmission, variable expression, and the meaning of genetic test results.NCBI+1Home Safety and Fall-Prevention Adjustments
Simple changes such as removing loose rugs, adding grab bars, and improving lighting can prevent injuries. The mechanism is environmental: when feet are weak and sensation is reduced, safer surroundings lower the chance of tripping and fractures.Orthopedic Physical Aids (Canes, Walkers, Wheelchairs)
Mobility aids are used when leg weakness becomes more severe. The purpose is safe mobility over longer distances and energy conservation. The mechanism is mechanical support: transferring part of body weight to the arms or to wheels reduces strain on weak leg muscles and improves balance.Respiratory and Vocal-Cord Support
Some autosomal dominant CMT forms involve diaphragm or vocal-cord weakness. Breathing exercises, non-invasive ventilation, and speech therapy can help. The mechanism is supporting breathing muscles during sleep or illness and training alternative voice strategies when vocal cords do not move normally.Global Genes+1Orthopedic Management of Foot Deformities (Non-surgical)
Serial casting, night splints, and stretching can help reduce early contractures in the feet. The purpose is to delay or reduce the need for surgery. The mechanism is gradual, gentle repositioning of joints and soft tissues to counteract muscle imbalance between weaker and stronger muscle groups.Exercise Programs (Low-Impact Aerobic Fitness)
Supervised, low-impact exercise such as swimming, recumbent cycling, and gentle walking helps maintain cardiovascular fitness. The mechanism is improving heart and lung function and muscle endurance without overloading fragile joints or causing over-fatigue in denervated muscles.PMCNutrition Counseling and Weight Management
Dietitians help maintain a healthy weight and adequate nutrients. The purpose is to avoid extra stress on weak legs and to support nerve and muscle health. The mechanism is balancing calorie intake with activity and providing enough protein, vitamins, and minerals important for nerve function, such as B-vitamins.Education About Neurotoxic Medications and Lifestyle Risks
Some chemotherapy drugs and other agents can worsen CMT neuropathy. Education helps patients and doctors avoid or monitor these medicines. The mechanism is risk reduction: knowing which drugs are potentially neurotoxic allows safer choices or closer follow-up when treatment is unavoidable.Charcot-Marie-Tooth Association+1
Drug Treatments
Important note: there is currently no FDA-approved drug that specifically cures Charcot-Marie-Tooth disease or its associated deafness. Medicines are used to manage symptoms such as neuropathic pain, muscle spasms, mood issues, and sleep disturbance. Doses below are typical adult starting ranges from FDA labeling and general clinical practice, but real prescriptions must always be adjusted by a qualified doctor.PMC+1
Gabapentin (Neurontin and others)
Gabapentin is an anticonvulsant widely used for neuropathic pain. A common adult dose for nerve pain is 900–1800 mg per day, split into three doses, titrated slowly. The purpose is to reduce burning, tingling, and electric-shock-like pain. It acts by binding to voltage-gated calcium channel subunits in the nervous system, reducing excitatory neurotransmitter release. Side effects can include dizziness, sleepiness, and weight gain.FDA Access Data+2FDA Access Data+2Pregabalin (Lyrica, Lyrica CR)
Pregabalin is related to gabapentin and is also used for neuropathic pain. Typical starting doses are 150 mg per day divided into two or three doses, with possible increase up to 300–450 mg per day as tolerated. The purpose is similar: pain relief and better sleep. The mechanism is binding to alpha-2-delta subunits of calcium channels to reduce abnormal nerve firing. Common side effects include dizziness, sleepiness, swelling of legs, and weight gain.FDA Access Data+2FDA Access Data+2Duloxetine (Cymbalta)
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) approved for diabetic neuropathic pain and depression. Typical adult neuropathic pain doses are 60 mg once daily, sometimes 30–60 mg twice daily. The purpose is to relieve nerve pain and also help mood and anxiety. The mechanism is increasing serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord. Side effects may include nausea, dry mouth, sleep changes, and increased sweating.FDA Access Data+2FDA Access Data+2Amitriptyline
Amitriptyline is a tricyclic antidepressant used off-label at low dose (for example 10–25 mg at night, slowly increased) for neuropathic pain. The purpose is pain reduction and improved sleep. It works by blocking reuptake of serotonin and norepinephrine and blocking certain ion channels, reducing pain signal transmission. Side effects can include dry mouth, constipation, drowsiness, and in some cases heart rhythm changes, especially at higher doses.Nortriptyline
Nortriptyline is another tricyclic often better tolerated than amitriptyline. Doses may start at 10 mg at night, increasing slowly. The purpose and mechanism are similar: enhance descending pain inhibition. It can cause dry mouth, constipation, and sleepiness, so doctors monitor heart health and interactions with other drugs.Topical Lidocaine Patches
Lidocaine 5% patches can be applied to painful areas (for example, feet) for up to 12 hours in 24 hours. The purpose is local pain relief with minimal systemic side effects. The mechanism is blocking sodium channels in peripheral nerve endings, reducing pain signal generation. Side effects are usually mild skin irritation or redness at the patch site.Capsaicin Topical Preparations (Low- or High-Dose Patches)
Capsaicin cream or patches provide local pain relief. The purpose is long-term reduction in burning pain. The mechanism is depletion and desensitization of substance P and TRPV1 receptors in sensory nerve endings, which reduces pain signaling after an initial burning sensation. Side effects include local burning and redness, especially at the start of use.Non-steroidal Anti-Inflammatory Drugs (NSAIDs)
NSAIDs such as ibuprofen or naproxen may be used for musculoskeletal pain, joint strain, and post-surgical pain. They are usually taken with food at the lowest effective dose and for limited periods. The mechanism is inhibition of cyclo-oxygenase enzymes, reducing prostaglandin production and inflammation. Side effects can include stomach upset, ulcers, kidney strain, and increased bleeding risk.Acetaminophen (Paracetamol)
Acetaminophen can be used for mild pain or fever. Typical adult doses are up to 3000–4000 mg per day, divided, but doctors may choose lower limits to protect the liver. The mechanism is central inhibition of pain pathways, although the exact mechanism is still debated. It does not reduce inflammation. Side effects at normal doses are usually few, but overdose can cause serious liver damage.Baclofen (oral or intrathecal)
Baclofen is a GABA-ergic muscle relaxant used for spasticity. In some CMT patients with spasticity or severe cramps, low oral doses (for example starting 5–10 mg three times a day) may be used and adjusted by a doctor. The purpose is to reduce muscle stiffness and spasms. The mechanism is agonism at GABA-B receptors in the spinal cord, reducing excitatory neurotransmission. Side effects include drowsiness, weakness, and, if stopped suddenly, withdrawal symptoms.FDA Access Data+3FDA Access Data+3FDA Access Data+3Tizanidine
Tizanidine is another antispastic drug sometimes used to reduce muscle tone and cramps. It works as an alpha-2 adrenergic agonist in the spinal cord, reducing excitatory input to motor neurons. Common side effects include drowsiness, dry mouth, and low blood pressure. Liver function needs monitoring in some patients.Clonazepam
Clonazepam is a benzodiazepine that can help with severe nighttime cramps, anxiety, or tremor. The mechanism is enhancing GABA-A receptor activity, which calms overactive neural circuits. Doctors use the lowest effective dose because of risks of dependence, drowsiness, and falls.Selective Serotonin Reuptake Inhibitors (SSRIs)
SSRIs such as sertraline or escitalopram may be used to treat depression and anxiety related to chronic illness. The mechanism is increasing serotonin levels in brain synapses, which can improve mood and coping. Side effects can include nausea, headaches, and sexual dysfunction, so regular follow-up is needed.Sleep Aids (Short-Term, Carefully Monitored)
Short-term use of melatonin or, in selected cases, prescription hypnotic drugs may help insomnia caused by pain or worry. The purpose is restoring a healthier sleep routine, which supports nerve function and mood. The mechanism varies by drug but often involves enhancing natural sleep pathways in the brain. These medicines must be used with caution to avoid dependence and daytime sedation.Antiemetics and GI-Supportive Medications
Some pain medicines cause nausea or constipation. Antiemetic drugs and stool softeners may be added to support tolerability. They work by blocking receptors involved in nausea or by drawing water into the bowel to ease stool passage. Doctors aim to keep regimens as simple as possible.Vitamin B12 Injections (If Deficient)
If blood tests show B12 deficiency, injections can correct it. The purpose is supporting myelin and nerve health. The mechanism is replenishing B12, which is vital for DNA synthesis and myelin maintenance. It is not a cure for genetic CMT but can prevent additional nerve damage from deficiency.Vitamin D and Calcium Supplements (If Low)
Many people with chronic disability are low in vitamin D. Supplements support bone health and lower fracture risk. The mechanism is improved calcium absorption and bone remodeling. Levels should be checked with blood tests to avoid overdose.Experimental Agents in Clinical Trials (e.g., NMD670, Gene Therapies)
Several investigational drugs and gene therapies, such as NMD670 or siRNA and AAV-based treatments, have FDA orphan-drug designation for CMT subtypes. These are generally available only inside clinical trials or special programs. Their mechanisms include modulating ion channels or correcting over-expressed genes such as PMP22. Side effects and true benefits are still being studied.Pharmafile+5FDA Access Data+5FDA Access Data+5Analgesic Combinations (Under Specialist Supervision)
In some cases, combinations of neuropathic pain medicines and simple analgesics are used. The purpose is multi-mechanism pain control with lower doses of each drug. The mechanism is targeting several steps in the pain pathway. Doctors monitor for interactions and sedation.Medications for Comorbidities (Blood Pressure, Diabetes, etc.)
Controlling other conditions such as diabetes or high blood pressure is vital, because they can worsen neuropathy and hearing loss. The mechanism is removing extra stress on blood vessels and nerves. Examples include antihypertensives and glucose-lowering drugs, chosen and adjusted by physicians based on standard guidelines.
Dietary Molecular Supplements
These supplements do not replace medical care. They are usually considered only after discussion with a doctor, especially to avoid interactions with prescribed medicines. Evidence for direct benefit in autosomal dominant CMT and deafness is still limited, so these are mainly supportive.PMC+1
Omega-3 Fatty Acids (Fish Oil, Algal Oil)
Omega-3s (EPA/DHA) may support nerve membrane health and have anti-inflammatory effects. Typical supplemental doses are around 1000–2000 mg of combined EPA/DHA daily with food, as advised by a clinician. Mechanistically, they integrate into cell membranes, influence eicosanoid production, and may reduce low-grade inflammation that can irritate nerves.Alpha-Lipoic Acid
Alpha-lipoic acid is an antioxidant used in some neuropathy studies. Common supplemental doses in adults are 300–600 mg per day, usually with meals. It can help reduce oxidative stress and may modestly improve nerve blood flow and glucose handling. Mechanism: recycling other antioxidants and reducing free radical damage in nerve tissue.Coenzyme Q10 (CoQ10)
CoQ10 is involved in mitochondrial energy production. Doses often range from 100–300 mg per day. In theory, improving mitochondrial function may support muscles and nerves that are already under stress from demyelination or axonal loss. It acts as an electron carrier and antioxidant in the inner mitochondrial membrane.B-Complex Vitamins (B1, B6, B12, Folate)
Balanced B-complex supplements ensure adequate levels of vitamins important for nerve metabolism and myelin maintenance. Doses vary by product but typically stay within daily recommended ranges. Mechanistically, these vitamins are co-factors in energy pathways, methylation, and neurotransmitter synthesis. Very high B6 doses can harm nerves, so dosing must be cautious.Vitamin D3
Vitamin D3 supports bone health and immune regulation. Doses may range from 800–2000 IU daily, adjusted to blood levels. Mechanism: regulating calcium handling and bone remodeling, and modulating immune cells. Adequate vitamin D helps prevent fractures in people with foot deformities or balance problems.Magnesium
Magnesium participates in nerve conduction and muscle relaxation. Supplemental doses of 200–400 mg per day are common, depending on kidney function and diet. The mechanism is acting as a co-factor in ATP reactions and modulator of NMDA receptors, potentially calming over-excitable neurons and reducing cramps.Acetyl-L-Carnitine
Acetyl-L-carnitine may support mitochondrial function and nerve regeneration in some neuropathy settings. Typical doses in studies are around 500–1000 mg twice daily. It helps transport fatty acids into mitochondria for energy, which may support metabolically stressed neurons and muscle cells.N-Acetylcysteine (NAC)
NAC is a precursor to glutathione, a key antioxidant. Doses often range from 600–1200 mg per day. Mechanism: boosting glutathione levels, helping cells deal with oxidative stress, which may be increased in chronic neuropathy. It may also have mild anti-inflammatory and mucolytic effects.Zinc and Selenium (Within Recommended Limits)
Both trace elements are important for antioxidant enzymes and immune function. Low-dose supplements can correct deficiency; exact dosing depends on diet and lab results. Mechanism: serving as co-factors for antioxidant enzymes such as glutathione peroxidase and supporting immune defense, which is important when mobility and respiratory function are limited.Probiotics and Prebiotics
Gut microbiome health may influence immunity and inflammation. Probiotics (live beneficial bacteria) and prebiotics (fiber that feeds them) can support gut health. Mechanism: improving gut barrier function, altering immune signaling, and possibly reducing systemic inflammation, which indirectly supports nerve and general health.
Immunity-Booster, Regenerative and Stem-Cell–Related Drugs
These areas are highly experimental in CMT. For now, most “regenerative” options are in research settings such as clinical trials.
Experimental Gene Therapies (AAV-Based)
Some CMT subtypes are being studied with AAV9-based gene therapies carrying healthy copies of disease-related genes. The purpose is to correct or compensate for the defective gene in nerve cells. The mechanism is delivering DNA via viral vectors into target cells, where it can drive expression of a normal protein. Safety, dosing, and durability are still under study.FDA Access Data+2ClinicalTrials.gov+2siRNA-Based Therapies Targeting PMP22 Overexpression
In CMT1A, overexpression of PMP22 is a major problem. Double-stranded siRNA drugs are designed to reduce PMP22 mRNA levels. The purpose is to normalize myelin protein dosage. The mechanism is RNA interference, where siRNA guides cellular complexes to degrade specific mRNA molecules. These agents are currently in orphan-drug and clinical-trial stages, not routine use.FDA Access Data+1Small-Molecule Nerve-Supportive Agents (e.g., NMD670)
NMD670 is an investigational small molecule targeting skeletal muscle chloride channels to improve muscle response to weak nerve signals. The purpose is stronger, more reliable muscle contraction in CMT. The mechanism is modulating ClC-1 channels, reducing muscle fiber hyperexcitability and improving efficiency of neuromuscular transmission. Studies are continuing to confirm long-term safety and benefit.Pharmafile+3Charcot-Marie-Tooth Disease+3NMD Pharma+3Growth-Factor–Like Approaches (Research Only)
Some preclinical studies in neuropathies look at neurotrophic factors that support neuron survival, such as NGF or BDNF analogues or modulators. The purpose is to protect or regrow nerve fibers. The mechanism is binding to receptors on neurons and Schwann cells, activating signaling pathways that promote survival, myelination, and repair. At present, such approaches for CMT are experimental.Immune-Modulating Treatments (For Overlapping Autoimmune Features)
If a patient also has autoimmune neuropathy or autoimmune inner-ear disease, immune-modulating drugs like corticosteroids, IVIG, or other agents may be used under specialist care. The mechanism is dampening abnormal immune attacks on myelin or inner-ear structures. These are not standard for pure genetic CMT but may be considered in selected overlapping cases.Stem-Cell Research (Very Early Stage)
Stem-cell therapies aim to replace or support damaged Schwann cells or neurons by transplanting cells that can differentiate into these lineages. The purpose is long-term regeneration of peripheral nerves. The mechanism is complex and includes cell replacement, release of trophic factors, and modulation of local immune responses. At present, stem-cell therapies for CMT and related deafness are experimental and should only be accessed through approved trials.PMC+1
Surgeries
Foot and Ankle Reconstructive Surgery
Many people with CMT develop high-arched feet (pes cavus), claw toes, and ankle instability. Orthopedic surgery can realign bones, lengthen tight tendons, and balance opposing muscles. The purpose is a more stable, plantigrade foot that reduces pain, improves shoe fit, and lowers fall risk.Tendon Transfers
In tendon transfer surgery, stronger muscles are re-routed to take over functions of weak ones, for example moving a functioning tendon to lift the foot. The purpose is to correct foot drop and improve active movement. The mechanism is using remaining muscle power in a new way to restore a key motion, even though the original muscles are weak.Spinal or Lower-Limb Deformity Correction
Some patients develop scoliosis or knee/hip misalignment due to chronic muscle imbalance. Surgical correction can include spinal fusion or osteotomies (bone cuts). The purpose is to improve posture, reduce chronic pain, and prevent progressive deformity that compresses lungs or nerves.Cochlear Implant Surgery
As described above, cochlear implants are placed surgically when severe hearing loss no longer responds to hearing aids. The surgeon threads an electrode array into the cochlea and positions a receiver under the skin behind the ear. The purpose is to deliver electrical sound signals directly to the auditory nerve to improve speech understanding and quality of life.Taylor & Francis Online+3PMC+3Charcot-Marie-Tooth News+3Airway and Vocal-Cord Procedures
If vocal-cord paralysis or severe airway issues arise, ENT surgeons may perform procedures such as cord medialization or tracheostomy. The purpose is to protect breathing and allow safer swallowing and communication. The mechanism is mechanical support or repositioning of vocal cords, improving closure or airway size.
Preventions
Because the condition is genetic, it cannot be completely prevented, but many complications can be reduced:
Early Diagnosis and Regular Neurological Follow-Up – allows early start of physiotherapy, hearing support, and safety measures.
Avoiding Neurotoxic Medications When Possible – chemotherapy agents like vincristine and certain others should be used cautiously or avoided when safer options exist.Charcot-Marie-Tooth Association
Protecting Feet from Injury – well-fitting shoes, daily foot checks, and prompt treatment of cuts reduce ulcers and infections.
Maintaining Healthy Body Weight – lowers stress on weak legs and joints and reduces fall risk.
Regular, Gentle Exercise – prevents deconditioning and supports heart and lung health without over-straining muscles.PMC
Home Safety Adjustments – grab bars, good lighting, and removing trip hazards help prevent falls.
Vaccinations and Infection Prevention – keeping vaccinations current, including respiratory vaccines, can reduce infections that worsen weakness.
Hearing Protection – avoiding loud noise and using ear protection may slow further damage to remaining hearing.Charcot-Marie-Tooth Association+1
Managing Other Conditions (e.g., Diabetes, Thyroid Disease) – good control of comorbidities reduces extra harm to nerves.
Family Planning and Genetic Counseling – allows informed decisions about having children and early testing when desired.NCBI+1
When to See Doctors
A person with autosomal dominant CMT neuropathy and deafness should see a doctor or specialist team regularly, and urgently if there are worrisome changes. You should seek medical help when weakness, falls, or foot deformities suddenly get worse; when pain becomes severe or unmanageable; if new breathing problems, swallowing trouble, or sudden voice changes appear; or if hearing suddenly drops, tinnitus appears, or communication becomes very difficult. People should also see doctors before starting any new medicine that might affect nerves, before pregnancy, and whenever mood changes, depression, or anxiety make daily life hard. For children, any delay in walking, frequent tripping, or late speech and poor hearing should prompt evaluation by pediatric neurology and audiology as early as possible.BJORL+3NCBI+3MedlinePlus+3
What to Eat and What to Avoid
Eat a Balanced, Whole-Food Diet – plenty of vegetables, fruits, whole grains, lean protein, and healthy fats gives nerves and muscles the nutrients they need.
Include Omega-3-Rich Foods – fatty fish, flaxseed, and walnuts support cell membranes and may reduce inflammation.
Ensure Enough Protein – fish, eggs, beans, and dairy support muscle repair and maintenance.
Get Adequate B-Vitamins and Folate – through leafy greens, legumes, whole grains, and fortified foods, unless your doctor advises extra supplements.
Maintain Good Hydration – water supports circulation and helps prevent constipation from some pain medicines.
Limit Sugary Foods and Soft Drinks – to avoid weight gain and high blood sugar, which can worsen neuropathy.
Avoid Heavy Alcohol Use – alcohol is directly toxic to nerves and can speed nerve damage.
Limit Very High-Salt, Ultra-Processed Foods – to support heart and kidney health, especially if you use certain medicines.
Be Cautious with “Mega-Dose” Supplements – very high doses, especially of vitamin B6 or certain herbs, can harm nerves or interact with medicines; always ask a doctor first.
Adapt Diet to Any Other Conditions – such as diabetes, kidney disease, or celiac disease, following specialist advice to protect global health and nerve function.PMC+1
Frequently Asked Questions
1. Is autosomal dominant Charcot-Marie-Tooth neuropathy and deafness curable?
At present, there is no cure that reverses the genetic change or fully restores nerves and hearing. Treatment aims to slow progression, reduce symptoms, and protect function. Gene-targeted and regenerative therapies are under active research but are not yet routine clinical care everywhere.NCBI+1
2. Will everyone with the gene become severely disabled or totally deaf?
No. Autosomal dominant conditions often show “variable expressivity,” meaning people in the same family can have very different severity. Some may have mild weakness and partial hearing loss, while others need braces, surgeries, and cochlear implants. The exact gene variant and other biological and environmental factors all play a role.MalaCards+1
3. How is this condition diagnosed?
Diagnosis usually combines clinical examination, nerve conduction studies and EMG, genetic testing, and hearing tests such as audiometry. Doctors look at family history, pattern of weakness, and nerve conduction velocities, then confirm by identifying a disease-causing variant in genes associated with CMT and deafness, such as PMP22 and others.NCBI+2BJORL+2
4. Can children be tested before symptoms appear?
Genetic testing of at-risk children is a sensitive subject and depends on local laws, ethics, and family wishes. In some cases, early diagnosis can allow closer monitoring and early support; in others, families prefer to wait until a child is mature enough to participate in decision-making. A genetic counselor can explain options and implications in detail.
5. Do hearing aids always work for CMT-related deafness?
Hearing aids help many but not all people. In some CMT cases, the main problem is auditory neuropathy, where timing of nerve signals is disturbed; standard amplification may help less. When hearing aids are no longer useful, cochlear implants or other assistive devices may give better speech understanding.PubMed+3Charcot-Marie-Tooth Association+3Charcot-Marie-Tooth Disease+3
6. Are cochlear implants safe in people with CMT?
Published case series suggest that cochlear implants can be safe and effective in selected CMT patients, improving hearing and quality of life. As with any surgery, there are risks, and not everyone is a candidate. Evaluation at a specialized cochlear implant center is essential to weigh benefits and risks for each individual.PubMed+3PMC+3ScienceDirect+3
7. Can exercise make the neuropathy worse?
Appropriate, low-impact exercise supervised by physiotherapists generally helps rather than harms. Over-exertion or very heavy resistance training, especially without guidance, may cause excessive fatigue and strain. The goal is moderate, regular activity tailored to your abilities, not extreme workouts.PMC+1
8. What about pregnancy and childbirth?
Many people with CMT have healthy pregnancies. However, pregnancy can temporarily worsen weakness or balance problems. Women should consult neurology and obstetric teams beforehand to plan safe delivery and review medications. Genetic counseling can discuss inheritance risk for the baby.NCBI+1
9. Can this condition affect breathing?
In some CMT subtypes, especially those involving respiratory muscles or vocal cords, breathing can be affected. People may notice shortness of breath during sleep or infections. Pulmonology evaluation and, if needed, non-invasive ventilation or surgery can help.Global Genes+1
10. Why is pain sometimes so severe if the nerves are “dying”?
Neuropathic pain often arises from damaged but still active nerves that misfire, sending false pain signals. These signals are then amplified by spinal cord and brain circuits. Even when sensation is reduced, abnormal discharges can cause intense burning or electric pain. Medicines and psychological therapies aim to calm these circuits.PMC+2FDA Access Data+2
11. Are there special risks with anesthesia or surgery?
Because of neuropathy, muscle weakness, and sometimes respiratory issues, anesthesia must be planned carefully. Certain drugs may need to be avoided or doses adjusted. Patients should tell anesthesiologists about their CMT, hearing loss, and all medications before any operation.
12. Should family members without symptoms be tested?
This is a personal decision. Some relatives want to know their status for family planning or early monitoring; others prefer not to know unless symptoms appear. Genetic counseling provides unbiased information to help families decide what is best for them.NCBI+1
13. Can diet alone fix or reverse the neuropathy or deafness?
No diet can reverse the underlying genetic defect. However, good nutrition supports general health, bones, and muscles, and can prevent extra nerve damage from vitamin deficiency or diabetes. Diet is a helpful support, not a cure.PMC+1
14. How can students or workers with this condition succeed in school or jobs?
With reasonable accommodations such as accessible classrooms, assistive listening devices, extra time for tasks, ergonomic workstations, and flexible schedules, many people with CMT and deafness complete education and maintain employment. Occupational therapy, vocational counseling, and disability support services can help identify needed adjustments.
15. What is the long-term outlook (prognosis)?
Most forms of autosomal dominant CMT neuropathy and deafness get worse slowly over many years. Life expectancy is usually near normal, but mobility and hearing can become significantly limited without good support. With early diagnosis, regular monitoring, and combined physical, hearing, psychological, and social care, many people achieve a good quality of life and remain active in their families, schools, and communities.NCBI+2MedlinePlus+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 25, 2025.
